Patients with grade 3 glioma expressing high levels of Hsp70 exhibit a significantly increased frequency of CD3−/CD56+ NK cells, thereby supporting the potency of mHsp70 and vesicular Hsp70 in stimulating NK cells in these patients. This evidence concerns the gene NCAM1 and glioma.